Media Summary: Dorene Rentz, PsyD, is a Professor of Neurology at Harvard Medical School with dual appointments in the Departments of ... Learn more about the Emory Healthy Brain Study here Don't forget to "Like" and Subscribe to our channel to ... Glenn Smith, PhD from the University of Florida, Gainesville, FL talks to us about commercially available

Computerized Cognitive Testing - Detailed Analysis & Overview

Dorene Rentz, PsyD, is a Professor of Neurology at Harvard Medical School with dual appointments in the Departments of ... Learn more about the Emory Healthy Brain Study here Don't forget to "Like" and Subscribe to our channel to ... Glenn Smith, PhD from the University of Florida, Gainesville, FL talks to us about commercially available Results from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study baseline assessments have identified ... Lecture by Dixie J Woolston, Mayo Clinic Arizona/Scottsdale, United States on “Utilizing Chris Edgar, Senior Vice President of Clinical Science at Cogstate, shares poster data presented during the AAIC 2020 meeting.

Building upon this and integrating objective measures into EMA, we get ecological momentary

Photo Gallery

Computerized Cognitive Testing
Computerized Cognitive Testing
Computerized Cognitive Testing: Advantages for Clinical Trials
Computerized Cognitive Assessment for Early Detection of Neurodegenerative Disease
Cognitive Testing
Having a cognitive assessment
Remote Cognitive Assessment Considerations and Capabilities for Clinical Trials | Cogstate
Can computerized cognitive training help patients?
C3 Computerized Cognitive Battery | Results from A4 Study Baseline Data
Utilizing computerized cognitive testing in neurology practices | Neurology 2024
Initial Exploration of a Brain Age Score | Computerized Cognitive Assessments
Using Cogstate Digital Tests to Identify Cognitive Impairment in Alzheimer’s Disease Clinical Trials
View Detailed Profile
Computerized Cognitive Testing

Computerized Cognitive Testing

Dorene Rentz, PsyD, is a Professor of Neurology at Harvard Medical School with dual appointments in the Departments of ...

Computerized Cognitive Testing

Computerized Cognitive Testing

Computerized cognitive testing

Computerized Cognitive Testing: Advantages for Clinical Trials

Computerized Cognitive Testing: Advantages for Clinical Trials

Cogstate's

Computerized Cognitive Assessment for Early Detection of Neurodegenerative Disease

Computerized Cognitive Assessment for Early Detection of Neurodegenerative Disease

So

Cognitive Testing

Cognitive Testing

Learn more about the Emory Healthy Brain Study here http://bit.ly/2fo6r0P Don't forget to "Like" and Subscribe to our channel to ...

Having a cognitive assessment

Having a cognitive assessment

The simplest

Remote Cognitive Assessment Considerations and Capabilities for Clinical Trials | Cogstate

Remote Cognitive Assessment Considerations and Capabilities for Clinical Trials | Cogstate

The ability to

Can computerized cognitive training help patients?

Can computerized cognitive training help patients?

Glenn Smith, PhD from the University of Florida, Gainesville, FL talks to us about commercially available

C3 Computerized Cognitive Battery | Results from A4 Study Baseline Data

C3 Computerized Cognitive Battery | Results from A4 Study Baseline Data

Results from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study baseline assessments have identified ...

Utilizing computerized cognitive testing in neurology practices | Neurology 2024

Utilizing computerized cognitive testing in neurology practices | Neurology 2024

Lecture by Dixie J Woolston, Mayo Clinic Arizona/Scottsdale, United States on “Utilizing

Initial Exploration of a Brain Age Score | Computerized Cognitive Assessments

Initial Exploration of a Brain Age Score | Computerized Cognitive Assessments

Chris Edgar, Senior Vice President of Clinical Science at Cogstate, shares poster data presented during the AAIC 2020 meeting.

Using Cogstate Digital Tests to Identify Cognitive Impairment in Alzheimer’s Disease Clinical Trials

Using Cogstate Digital Tests to Identify Cognitive Impairment in Alzheimer’s Disease Clinical Trials

Data supporting the identification of

Incorporating Technology Into Neuropsychological Assessment

Incorporating Technology Into Neuropsychological Assessment

Building upon this and integrating objective measures into EMA, we get ecological momentary